Comparing chronic obstructive pulmonary disease and depressive disorder in terms of inflammation-related biomarkers

被引:4
|
作者
Matujto-Balcerska, Elzbieta [1 ]
Sipowicz, Kasper [2 ]
Pietras, Tadeusz [3 ,4 ]
机构
[1] Med Univ Lodz, Dept Pneumonol, Lodz, Poland
[2] Mar Grzegorzewska Univ, Dept Interdisciplinary Disabil Studies, Warsaw, Poland
[3] Inst Psychiat & Neurol, Dept Psychiat 2, Warsaw, Poland
[4] Med Univ Lodz, Dept Clin Pharmacol, Lodz, Poland
关键词
cytokines; chronic obstructive pulmonary disease; depressive disorder; deiodinase iodothyronine; SEROTONIN; THERAPY; ALPHA;
D O I
10.5114/aoms/161803
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Chronic obstructive pulmonary disease (COPD) is characterized by the presence of depressive symptoms. Methods: Cytokine and deiodinase iodothyronines (DIOs) levels were evaluated in COPD patients and patients diagnosed with depressive disorder and control individuals. using enzyme-linked immunosorbent assays. Results: Interleukin 1 beta (IL-1 beta), and tumor necrosis factor-alpha (TNF-alpha) levels were higher in COPD and depression patients than in control individuals. DIO2 were significantly lower in COPD and recurrent depressive disorder (rDD) patients than in controls. Conclusions: Changes in the levels of IL-1 beta, TNF-alpha and DIO2 in COPD patients may explain the presence of depression in COPD patients.
引用
收藏
页码:814 / 819
页数:6
相关论文
共 50 条
  • [21] Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation
    Stockley, Robert A.
    Halpin, David M. G.
    Celli, Bartolome R.
    Singh, Dave
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (10) : 1195 - 1204
  • [22] Inflammatory biomarkers in chronic obstructive pulmonary disease
    Fattouh, Mona
    Alkady, Ola
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2014, 63 (04): : 799 - 804
  • [23] Blood biomarkers for chronic obstructive pulmonary disease
    Kalsheker, N.
    Matharoo-Ball, B.
    Coveney, C.
    Chappell, S.
    Ball, G.
    Creaser, C.
    Rees, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [24] The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease
    Sin, Don D.
    Man, S. F. Paul
    Marciniuk, Darcy D.
    Ford, Gordon
    FitzGerald, Mark
    Wong, Eric
    Yorks, Ernest
    Mainra, Rajesh R.
    Ramesh, Warren
    Melenka, Lyle S.
    Wilde, Eric
    Cowie, Robert L.
    Williams, Dave
    Gan, Wen Q.
    Rousseau, Roxanne
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (11) : 1207 - 1214
  • [25] Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease
    Antoniu, Sabina A.
    BIOMARKERS, 2010, 15 (02) : 97 - 103
  • [26] Revealing lncRNA Biomarkers Related to Chronic Obstructive Pulmonary Disease Based on Bioinformatics
    Han, Hui
    Hao, Lu
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 2487 - 2515
  • [27] Chronic obstructive pulmonary disease and inflammation of the airways
    Mal, H
    REVUE DES MALADIES RESPIRATOIRES, 2001, 18 (06) : S17 - S17
  • [28] Eosinophilic inflammation in chronic obstructive pulmonary disease
    Avdeev, S. N.
    Trushenko, N., V
    Merzhoeva, L. M.
    Ivanova, M. S.
    Kusraeva, Lv
    TERAPEVTICHESKII ARKHIV, 2019, 91 (10) : 144 - 152
  • [29] Airway inflammation in chronic obstructive pulmonary disease
    Gorska, Katarzyna
    Maskey-Warzechowska, Marta
    Krenke, Rafal
    CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (02) : 89 - 96